Minor
DurAVR™ THV EU-EFS
Final enrollment: 15 participants (planned 40)
Anteris Technologies Ltd.Not applicable NCT06510855 Registry history of NCT06510855 on ClinicalTrials.gov (opens the registry)
Updated
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Final enrollment: 15 participants (planned 40)
Anteris Technologies Ltd.Not applicable NCT06510855 Registry history of NCT06510855 on ClinicalTrials.gov (opens the registry)
Updated
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Not applicable | ||||
| NCT07194265 | A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System | Severe Aortic Stenosis | Recruiting | 2026-07-15 |
| NCT06510855 | DurAVR™ THV EU-EFS | Symptomatic Aortic Stenosis | Active, Not Recruiting | 2026-09-16 |
| NCT05182307 | DurAVR™ THV System: EMBARK Study | Symptomatic Aortic Stenosis | Active, Not Recruiting | 2026-06-26 |
| NCT05712161 | Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study | Aortic Stenosis | Active, Not Recruiting | 2026-06-26 |
Heart Disease (4)